4//SEC Filing
Loh Jeremy 4
Accession 0001511848-11-000005
CIK 0001162194other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:19 PM ET
Size
17.3 KB
Accession
0001511848-11-000005
Insider Transaction Report
Form 4
FLUIDIGM CORPFLDM
Loh Jeremy
Director
Transactions
- Conversion
Common Stock
2011-02-15+128,025→ 1,799,511 total(indirect: I) - Conversion
Series E Preferred Stock
2011-02-15−1,047,955→ 751,556 total(indirect: I)→ Common Stock (1,047,955 underlying) - Conversion
Series D Preferred Stock
2011-02-15−623,531→ 128,025 total(indirect: I)→ Common Stock (623,531 underlying) - Conversion
Series C Preferred Stock
2011-02-15−128,025→ 0 total(indirect: I)→ Common Stock (125,025 underlying) - Conversion
Common Stock
2011-02-15+1,047,955→ 1,047,955 total(indirect: I) - Conversion
Common Stock
2011-02-15+623,531→ 1,671,486 total(indirect: I)
Footnotes (8)
- [F1]Represents shares of Common Stock issued upon conversion of shares of Series E Preferred Stock on a 1-for 1.300053676865 basis.
- [F2]Not applicable.
- [F3]Biomedical Sciences Investment Fund Pte Ltd is the record holder of the securities reported.
- [F4]EDB Investments Pte Ltd, or EDB Investments, is the parent entity of Biomedical Sciences Investment Fund Pte Ltd and Singapore Bio-Innovations Pte Ltd. The Economic Development Board of Singapore, or EDB, is the parent entity of EDB Investments. EDB is a Singapore government entity. EDB Investments, EDB and the Singapore government may be deemed to have shared voting and dispositive power over the shares owned beneficially and of record by Biomedical Sciences Investment Fund Pte Ltd and Singapore Bio-Innovations Pte Ltd. Jeremy Loh, the reporting person, is one of the Issuer's directors and a Vice President (Investments), San Francisco Center for EDB Investments Pte Ltd, Singapore. Dr. Loh disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in such shares.
- [F5]Represents shares of Common Stock issued upon the conversion of shares of Series C Preferred Stock and Series D Preferred Stock on a 1-for-1 basis.
- [F6]Singapore Bio-Innovations Ptd Ltd is the record holder of the securities reported.
- [F7]Each share of Series E Preferred Stock converted into 1.300053676865 share of Common Stock on February 15, 2011 and has no expiration date.
- [F8]Each share of Series C Preferred Stock or Series D Preferred Stock converted into one share of Common Stock on February 15, 2011 and has no expiration date.
Documents
Issuer
FLUIDIGM CORP
CIK 0001162194
Entity typeother
Related Parties
1- filerCIK 0001511848
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 6:19 PM ET
- Size
- 17.3 KB